Table 1.

Patient characteristics grouped by composite right ventricular dysfunction variable

Variable	Right Ventricular Dysfunction		p Value
	No (n=92)	Yes (n=49)
Age (years)	63 ± 16	61 ± 17	0.56
African American	75 (82%)	34 (69%)	0.1
Male	46 (47%)	30 (61%)	0.1
Systolic blood pressure (mmHg)	149 ± 31	145 ± 34	0.49
Heart rate (beats per minute)	80 ± 17	85 ± 12	0.06
General medical service	71 (77%)	36 (75%)	0.77
Volume overload on chest X-ray	46 (71%)	22 (65%)	0.54
Hemoglobin (g/dL)	11.9 ± 2.0	12.7 ± 2.4	0.02*
Detectable troponin I	19 (21%)	16 (33%)	0.12
Blood urea nitrogen (mg/dL)	19 (14 to 28)	25 (18 to 33)	0.07
Serum sodium (mg/dL)	139.7 ± 5.2	138.4 ± 4.6	0.13
Admission glomerular filtration rate (mL/min/1.73m2)	59.6 ± 29.4	70.4 ± 22.8	0.03*
Admission serum creatinine (mg/dL)	1.3 (1.0 to 1.5)	1.2 (1.0 to 1.7)	0.98
B-type natriureetic peptide (pg/dL)	1279 (861 to 2299)	1987 (1042 to 4000)	0.003*
Maximum diuretic dose (mg/day)	80 (80 to 160)	120 (80 to 200)	0.03*
Thiazide use	12 (13%)	7 (14%)	0.84
Net fluid out (L)	3.9 (1.4 to 5.9)	4.5 (1.5 to 8.5)	0.28
Length of stay (days)	4 (3.3 to 6.0)	6 (4.0 to 8.0)	0.02*
Day peak creatinine (days)	4 (3 to 5)	2 (2 to 6)	0.11
Ejection fraction (%)	33 (16 to 55)	20 (10 to 29)	<0.001*
Early peak mitral inflow velocity/early peak annular tissue velocity (septal)	17.7 ± 8.3	19.7 ± 12.2	0.35
Early peak mitral inflow velocity/early peak annular tissue velocity (lateral)	12.1 ± 5.6	12.6 ± 8.3	0.68
Cardiac output (L/min)	4.9 ± 1.8	4.0 ± 1.7	0.01*
Left atrial size (cm)	4.7 ± 0.7	4.9 ± 0.8	0.13
Moderate or severe tricuspid regurgitation	37 (40%)	29 (59%)	0.03*
Lack of inspiratory inferior vena cava collapse	9 (10%)	13 (27%)	0.009*

^*represents a significant p value.